C.M. Bidwell & Associates’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03K | Buy |
+177
| New | +$3.03K | ﹤0.01% | 366 |
|
|
2024
Q3 | – | Sell |
-4
| Closed | -$632 | – | 542 |
|
|
2024
Q2 | $632 | Hold |
4
| – | – | ﹤0.01% | 429 |
|
|
2024
Q1 | $518 | Hold |
4
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $386 | Sell |
4
-1,549
| -100% | -$149K | ﹤0.01% | 461 |
|
|
2023
Q3 | $188K | Sell |
1,553
-28
| -2% | -$3.39K | 0.14% | 122 |
|
|
2023
Q2 | $181K | Hold |
1,581
| – | – | 0.13% | 133 |
|
|
2023
Q1 | $218K | Sell |
1,581
-97
| -6% | -$13.4K | 0.17% | 106 |
|
|
2022
Q4 | $217K | Hold |
1,678
| – | – | 0.17% | 114 |
|
|
2022
Q3 | $185K | Buy |
1,678
+1,058
| +171% | +$117K | 0.15% | 122 |
|
|
2022
Q2 | $46K | Buy |
620
+590
| +1,967% | +$43.8K | 0.04% | 283 |
|
|
2022
Q1 | $2K | Sell |
30
-1,615
| -98% | -$108K | ﹤0.01% | 483 |
|
|
2021
Q4 | $148K | Buy |
+1,645
| New | +$148K | 0.09% | 205 |
|